Journal of Shanghai Jiao Tong University (Medical Science) >

2010 , Vol. 30 >Issue 9: 1072

DOI: https://doi.org/10.3969/j.issn.1674-8115.2010.09.013

Monographic report (Medical imaging and nuclear medicine)

Progress of application of 18F-FDG PET and PET/CT in assessment of response of tumor to neoadjuvant chemotherapy

Expand
  • Department of Nuclear Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China

Online published: 2010-09-27

Supported by

Shanghai Leading Academic Discipline Project, S30203

Fold

Abstract

Neoadjuvant chemotherapy is increasingly widely used in the treatment of cancer, and 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) and PET/CT play a role in the early assessment of response to neoadjuvant chemotherapy, including tumor restaging, drug selection and prognosis prediction, which facilitate the design of therapeutic regimen and reduction of ineffective therapy.The progress of application of 18F-FDG PET and PET/CT in the assessment of response of tumor to neoadjuvant chemotherapy is reviewed in this paper.

Key words： positron emission tomography; 18F-fluorodeoxyglucose; tumor; neoadjuvant chemotherapy

Cite this article

ZHANG Min . Progress of application of 18F-FDG PET and PET/CT in assessment of response of tumor to neoadjuvant chemotherapy[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2010 , 30(9) : 1072 . DOI: 10.3969/j.issn.1674-8115.2010.09.013

Options
Outlines

/

〈 〉